A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma
一项针对高级别胶质瘤或胶质母细胞瘤患者的口服利沙万布林的 1/2a 期剂量探索研究和生物标志物评估
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102165
Lopez, Juanita Suzanne; Haefliger, Simon; Plummer, Ruth; Clement, Paul M; Jeffry Evans, Thomas R; Läubli, Heinz; Roth, Patrick; Kristeleit, Rebecca; Brazil, Lucy; Tabatabai, Ghazaleh; Wick, Antje; Wunderlich, Benjamin; Beebe, Kirk; Eisner, Joel Robert; Lane, Heidi; Engelhardt, Marc; Kaindl, Thomas; Hau, Peter; Hundsberger, Thomas; Steinbach, Joachim
